-
U-73122 in PLC Signaling: Applied Workflows
2026-09-29
U-73122 provides a practical way to test phospholipase C dependence across calcium flux, chemotaxis, inflammation, and cancer-cell invasion assays. This guide connects concentration selection, assay controls, and troubleshooting to evidence from neutrophil studies and QPRT-driven breast cancer research.
-
TH287 Radiosensitizes Castration-Resistant Prostate Cancer
2026-09-28
In PC-3 and DU-145 castration-resistant prostate cancer cells, the study found that TH287 enhanced the effects of ionizing radiation, with the strongest reported combination response when radiation followed drug exposure by 12 hours. The findings offer a timing hypothesis for CRPC radiosensitization experiments, while leaving dose optimization, mechanism, and relevance beyond these cell models to be tested.
-
BmTyr Proximity Labeling in Primary T Cells
2026-09-27
The study introduces a click-compatible, biotin-free BmTyr proximity-labeling platform for subcellular proteome profiling in primary T cells. Its findings include validation of nuclear TNFα-pathway components and evidence for a chromatin-associated localization of NKAP, while its modular labeling chemistry supports multiple downstream detection and enrichment options.
-
ACE2–Sirt1 Signaling in Sepsis Cardiomyopathy
2026-09-26
A February 2024 mouse study reports that ACE2 expression falls in septic heart tissue and that pharmacological ACE2 activation with diminazene aceturate improves cardiac outcomes alongside MasR–Sirt1-associated mitochondrial biogenesis. The paired activator and inhibitor experiments connect this pathway with cardiac function, inflammation, oxidative stress, and apoptosis, while leaving important questions about target specificity and translation to human sepsis.
-
Network Medicine Maps Flavonoids for Alzheimer’s Disease
2026-09-26
A 2025 network-medicine study screened flavonoids by their proximity to Alzheimer’s disease targets, identifying 48 candidates and prioritizing Apigenin alongside three other compounds for cellular testing. The work links Apigenin’s neuroprotective effects in cell models to apoptosis and inflammatory signaling, while highlighting the need for validation beyond these preclinical systems.
-
Nelfinavir Mesylate: Reading Ferroptosis Evidence
2026-09-25
Nelfinavir Mesylate is an established HIV-1 protease inhibitor with a research-supported connection to ferroptosis through DDI2–NFE2L1 signaling. This article explains how to separate antiviral activity from proteostasis effects and design more informative experiments.
-
Gramine Triggers Ferroptosis in TNBC via CUL3–MTDH
2026-09-25
A 2026 study reports that gramine suppresses triple-negative breast cancer (TNBC) by altering CUL3-dependent ubiquitination of MTDH and promoting ferroptosis. Chemical screening, target-engagement assays, genetic rescue, and xenograft experiments support this mechanism, while leaving important questions about dose, selectivity, and clinical translation open.
-
Amphotericin B: Assay Workflows and Optimization
2026-09-24
Build fungal assays around Amphotericin B’s sterol-dependent membrane damage, while separating direct antifungal effects from immune signaling and mammalian-cell toxicity. This practical guide covers dose selection, controls, stock handling, and what a seemingly unrelated canine-cell study can—and cannot—teach about assay design.
-
Mosquito Xenobiotic Clearance and OCT Expression
2026-09-24
Kennel and Rouhier’s 2025 study examines how female Aedes aegypti mosquitoes excrete injected xenobiotics and whether exposure changes the expression of six putative organic cation transporters. The results point to compound structure as an important influence on excretion and mortality, while measured transporter-expression responses were limited—an informative starting point, not yet a validated mosquito-control target.
-
Verbascoside PKC/NF-κB Inhibitor Workflow
2026-09-23
Build a controlled osteoclastogenesis and inflammatory-signaling workflow with Verbascoside, a small-molecule PKC/NF-κB inhibitor suited to pathway perturbation rather than endpoint-only screening. The guide connects dose selection, NF-κB DNA-binding assays, RANKL-induced osteoclast differentiation, and mechanistic validation to findings from a recent osteonecrosis study.
-
AZD2461: Rethinking PARP Inhibitor Translation
2026-09-23
AZD2461 is a novel PARP inhibitor for breast cancer research that connects PARP-1 inhibition, DNA repair pathway modulation, cell-cycle analysis, and resistance biology. This thought-leadership perspective outlines how to translate its activity into more informative in vitro and BRCA1-mutated tumor model studies.
-
Cycloastragenol Limits Bone Loss in GIONFH
2026-09-22
This in vivo study shows that cycloastragenol reduces glucocorticoid-induced osteonecrosis of the femoral head in rats by suppressing osteoclast activity, preserving trabecular bone, and improving local blood supply. Its value is mechanistic and translational: the findings identify the RANKL/OPG–osteoclast axis as a potential target for hip-preservation strategies, while requiring validation beyond the animal model.
-
Acifran Workflows for Lipid Signaling Research
2026-09-21
Acifran connects receptor-structure insights with practical Gi-coupled cAMP assays for investigating HCAR2/GPR109A and HCAR3/GPR109B biology. This workflow emphasizes matched receptor controls, solvent discipline, and troubleshooting strategies that distinguish genuine lipid signaling pathway modulation from assay artifacts.
-
Pioglitazone: PPARγ Agonist Research Workflows
2026-09-21
Pioglitazone offers a mechanistically anchored way to study PPARγ signaling across metabolic, macrophage, and neuroinflammatory models. This workflow-focused guide translates DSS-induced intestinal inflammation findings into practical assay design, formulation, controls, and troubleshooting decisions.
-
Diminazene Aceturate: From Probe to Pathway
2026-09-20
Diminazene Aceturate is more than a trypanocidal research reagent. Its established role in parasitic infection research and emerging use as an ACE2-activating pharmacological probe create a valuable framework for translational researchers—provided these research domains remain mechanistically and experimentally distinct.